Fig. 5From: High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancerCancer types studied using global molecular profiling techniques. Annotated are VitC dose group (A; high dose ≥1 mM or 1 g/kg, low dose ≤0.1 mM), type of profiling method used (B) and treatment type (C)Back to article page